Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,097 | 1,267 | 75.6% |
| Consulting Fee | $4,700 | 3 | 18.6% |
| Honoraria | $1,000 | 1 | 4.0% |
| Education | $454.70 | 5 | 1.8% |
| Travel and Lodging | $17.36 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Promius Pharma LLC | $4,639 | 27 | $0 (2019) |
| ABBVIE INC. | $2,578 | 148 | $0 (2024) |
| LEO Pharma Inc. | $1,638 | 126 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,492 | 133 | $0 (2024) |
| EPI Health, LLC | $1,392 | 18 | $0 (2022) |
| Janssen Biotech, Inc. | $1,245 | 138 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,204 | 44 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $957.07 | 22 | $0 (2023) |
| MAYNE PHARMA COMMERCIAL LLC | $933.40 | 67 | $0 (2024) |
| MAYNE PHARMA INC. | $867.70 | 83 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,942 | 105 | ABBVIE INC. ($342.97) |
| 2023 | $3,167 | 148 | MAYNE PHARMA COMMERCIAL LLC ($672.80) |
| 2022 | $3,084 | 198 | MAYNE PHARMA INC. ($559.03) |
| 2021 | $2,630 | 182 | AbbVie Inc. ($666.35) |
| 2020 | $2,938 | 121 | EPI Health, LLC ($1,055) |
| 2019 | $2,667 | 171 | Ortho Dermatologics, a division of Bausch Health US, LLC ($698.50) |
| 2018 | $6,522 | 184 | Promius Pharma LLC ($4,298) |
| 2017 | $2,320 | 168 | Valeant Pharmaceuticals North America LLC ($356.66) |
All Payment Transactions
1,277 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.80 | General |
| 12/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.60 | General |
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $35.17 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.74 | General |
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.93 | General |
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $73.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.48 | General |
| 10/09/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $31.76 | General |
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: DERMATOLOGY | ||||||
| 09/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 417 | 1,960 | $108,470 | $42,403 |
| 2022 | 6 | 419 | 1,914 | $106,440 | $38,795 |
| 2021 | 7 | 558 | 2,396 | $137,390 | $53,041 |
| 2020 | 6 | 483 | 2,055 | $113,130 | $36,440 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 410 | $65,600 | $27,792 | 42.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 71 | 202 | $20,200 | $9,158 | 45.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $7,400 | $3,345 | 45.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 108 | $3,240 | $1,151 | 35.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 112 | 1,203 | $12,030 | $958.84 | 8.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 378 | $60,480 | $24,552 | 40.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 77 | 189 | $18,900 | $8,200 | 43.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $8,400 | $2,997 | 35.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 12 | 13 | $3,900 | $1,086 | 27.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 106 | 1,200 | $12,000 | $992.51 | 8.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 44 | 92 | $2,760 | $967.58 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 174 | 478 | $76,480 | $32,767 | 42.8% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 84 | 216 | $21,600 | $9,793 | 45.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 62 | 62 | $12,400 | $5,235 | 42.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 74 | 134 | $4,020 | $1,470 | 36.6% |
| 17111 | Destruction of 15 or more non-cancerous skin growths | Office | 2021 | 11 | 15 | $4,500 | $1,405 | 31.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 142 | 1,479 | $14,790 | $1,398 | 9.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 11 | 12 | $3,600 | $973.74 | 27.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 155 | 416 | $66,560 | $22,408 | 33.7% |
| 11900 | Injection of up to 7 skin growths | Office | 2020 | 71 | 167 | $16,700 | $6,674 | 40.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 46 | 46 | $9,200 | $3,686 | 40.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 76 | 132 | $3,960 | $1,425 | 36.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 123 | 1,281 | $12,810 | $1,318 | 10.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 12 | 13 | $3,900 | $927.95 | 23.8% |
About Dr. Vaughan Graves, MD
Dr. Vaughan Graves, MD is a Dermatology healthcare provider based in Phila, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386687002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vaughan Graves, MD has received a total of $25,270 in payments from pharmaceutical and medical device companies, with $1,942 received in 2024. These payments were reported across 1,277 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($19,097).
As a Medicare-enrolled provider, Graves has provided services to 1,877 Medicare beneficiaries, totaling 8,325 services with total Medicare billing of $170,679. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Phila, PA
- Active Since 06/13/2006
- Last Updated 10/28/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1386687002
Products in Payments
- Sernivo Spray 120ml (Drug) $4,300
- Sitavig (Drug) $1,166
- ENSTILAR (Drug) $1,123
- DUPIXENT (Biological) $1,012
- SKYRIZI (Biological) $1,007
- TALTZ (Drug) $795.96
- ILUMYA (Biological) $791.80
- VTAMA (Drug) $737.38
- RINVOQ (Biological) $604.17
- REMICADE (Biological) $521.14
- ADBRY (Biological) $503.00
- Cimzia (Drug) $446.72
- Humira (Biological) $439.60
- HUMIRA (Biological) $422.60
- Impoyz (Drug) $418.61
- Tremfya (Drug) $397.75
- EUCRISA (Drug) $389.77
- OPZELURA (Drug) $368.07
- ONEXTON (Drug) $366.35
- Sumadan Wash (Drug) $350.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.